HCPCS code Q2056 — Ciltacabtagene car-pos t. Status: Active. Effective Oct 1, 2022. Source: CMS HCPCS Level II.

Q2056

Active

Ciltacabtagene car-pos t

Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Oct 1, 2022
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9498

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
57894-0111-01 Carvykti
57894-0111-02 Carvykti

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2022-Q4
    Ciltacabtagene car-pos t